image
Healthcare - Biotechnology - NASDAQ - US
$ 30.11
-4.53 %
$ 2.82 B
Market Cap
-7.88
P/E
Price Target Average
144.10%
Revenue Forecast Estimate
479.58%
EBIT Estimate
--36.38%
Net Income Estimate
31.46%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets Crinetics Pharmaceuticals, Inc.
image
Wall Street analysts predict an average 1-year price target for CRNX of $73.5 , with forecasts ranging from a low of $60 to a high of $91 .
CRNX Lowest Price Target Wall Street Target
60 USD 99.27%
CRNX Average Price Target Wall Street Target
73.5 USD 144.10%
CRNX Highest Price Target Wall Street Target
91 USD 202.23%
Price
Max Price Target
Min Price Target
Average Price Target
10010090908080707060605050404030302020Jul '24Jul '24Aug '24Aug '24Oct '24Oct '24Nov '24Nov '2420252025Feb '25Feb '25Apr '25Apr '25Jun '25Jun '25Jul '25Jul '25Aug '25Aug '25Oct '25Oct '25Nov '25Nov '2520262026Feb '26Feb '26Apr '26Apr '26
REVENUE FORECAST

Revenue Forecast Chart CRNX

image
$1.2b$1.2b$1.0b$1.0b$800.0m$800.0m$600.0m$600.0m$400.0m$400.0m$200.0m$200.0m$0.0$0.02018201820192019202020202022202220232023202420242025202520262026202720272028202820292029
EBIT FORECAST

EBIT Forecast Chart CRNX

image
$0.0$0.0($200.0m)($200.0m)($400.0m)($400.0m)($600.0m)($600.0m)($800.0m)($800.0m)($1.0b)($1.0b)($1.2b)($1.2b)2018201820192019202020202022202220232023202420242025202520262026202720272028202820292029
NET INCOME FORECAST

Net Income Chart CRNX

image
$300.0m$300.0m$200.0m$200.0m$100.0m$100.0m$0.0$0.0($100.0m)($100.0m)($200.0m)($200.0m)($300.0m)($300.0m)($400.0m)($400.0m)($500.0m)($500.0m)2018201820192019202020202022202220232023202420242025202520262026202720272028202820292029